Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Cipla
Julphar
Federal Trade Commission
US Department of Justice
Farmers Insurance
Moodys
Chubb

Generated: April 19, 2018

DrugPatentWatch Database Preview

Taro Pharm Inds Company Profile

« Back to Dashboard

What is the competitive landscape for TARO PHARM INDS, and what generic and branded alternatives to TARO PHARM INDS drugs are available?

TARO PHARM INDS has fourteen approved drugs.

There is one tentative approval on TARO PHARM INDS drugs.

Summary for Taro Pharm Inds
US Patents:0
Tradenames:12
Ingredients:12
NDAs:14

Drugs and US Patents for Taro Pharm Inds

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride SOLUTION;ORAL 202673-001 Jul 26, 2013 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds AMCINONIDE amcinonide CREAM;TOPICAL 076229-001 May 31, 2002 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds LAMOTRIGINE lamotrigine TABLET;ORAL 078525-004 Jan 27, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 075788-002 Sep 18, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
Baxter
Covington
Moodys
Express Scripts
Boehringer Ingelheim
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.